Weekly Investment Analysts’ Ratings Changes for Intuitive Surgical (ISRG)

Intuitive Surgical (NASDAQ: ISRG) recently received a number of ratings updates from brokerages and research firms:

• 4/19/2024 – Intuitive Surgical had its price target raised by analysts at Piper Sandler from $425.00 to $435.00. They now have an “overweight” rating on the stock.
• 4/19/2024 – Intuitive Surgical had its price target lowered by analysts at Robert W. Baird from $440.00 to $436.00. They now have an “outperform” rating on the stock.
• 4/19/2024 – Intuitive Surgical had its price target raised by analysts at Jefferies Financial Group Inc. from $365.00 to $375.00. They now have a “hold” rating on the stock.
• 4/19/2024 – Intuitive Surgical had its price target raised by analysts at BTIG Research from $412.00 to $421.00. They now have a “buy” rating on the stock.
• 4/8/2024 – Intuitive Surgical had its price target raised by analysts at Stifel Nicolaus from $420.00 to $430.00. They now have a “buy” rating on the stock.
• 4/3/2024 – Intuitive Surgical had its price target raised by analysts at Citigroup Inc. from $428.00 to $462.00. They now have a “buy” rating on the stock.
• 3/15/2024 – Intuitive Surgical had its “buy” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $420.00 price target on the stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $381.36 on Monday. The stock has a market capitalization of $135.27 billion, a price-to-earnings ratio of 68.84, a P/E/G ratio of 4.93 and a beta of 1.39. The company’s 50 day moving average price is $385.40 and its 200-day moving average price is $350.34. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.00 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 1,498 shares of the business’s stock in a transaction dated Friday, April 26th. The stock was sold at an average price of $369.92, for a total value of $554,140.16. Following the completion of the transaction, the executive vice president now owns 5,507 shares of the company’s stock, valued at approximately $2,037,149.44. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 226,928 shares of company stock valued at $87,833,828. 0.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently bought and sold shares of ISRG. Pinnacle Wealth Management Advisory Group LLC raised its position in Intuitive Surgical by 6.4% in the 3rd quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,479 shares of the medical equipment provider’s stock worth $432,000 after buying an additional 89 shares during the last quarter. Brighton Jones LLC grew its stake in shares of Intuitive Surgical by 0.9% during the 3rd quarter. Brighton Jones LLC now owns 8,881 shares of the medical equipment provider’s stock valued at $2,596,000 after acquiring an additional 79 shares during the period. Strs Ohio grew its stake in shares of Intuitive Surgical by 44.9% during the 3rd quarter. Strs Ohio now owns 163,422 shares of the medical equipment provider’s stock valued at $47,766,000 after acquiring an additional 50,650 shares during the period. AMF Tjanstepension AB increased its holdings in Intuitive Surgical by 637.3% in the 3rd quarter. AMF Tjanstepension AB now owns 127,624 shares of the medical equipment provider’s stock valued at $37,303,000 after acquiring an additional 110,314 shares during the last quarter. Finally, IFM Investors Pty Ltd increased its stake in Intuitive Surgical by 3.6% in the 3rd quarter. IFM Investors Pty Ltd now owns 74,314 shares of the medical equipment provider’s stock worth $21,721,000 after acquiring an additional 2,588 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.